200 related articles for article (PubMed ID: 21980169)
21. Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro.
Takahashi T; Kobayashi S; Fujino N; Suzuki T; Ota C; Tando Y; He M; Yamada M; Kurosawa S; Yamaya M; Kubo H
Exp Lung Res; 2013; 39(4-5):155-61. PubMed ID: 23550836
[TBL] [Abstract][Full Text] [Related]
22. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant.
Singh U; Devaraj S; Jialal I
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2216-21. PubMed ID: 16123325
[TBL] [Abstract][Full Text] [Related]
23. Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury.
Densmore JC; Signorino PR; Ou J; Hatoum OA; Rowe JJ; Shi Y; Kaul S; Jones DW; Sabina RE; Pritchard KA; Guice KS; Oldham KT
Shock; 2006 Nov; 26(5):464-71. PubMed ID: 17047516
[TBL] [Abstract][Full Text] [Related]
24. Receptor for advanced glycation end products involved in circulating endothelial cells release from human coronary endothelial cells induced by C-reactive protein.
Zhou S; Gao L; Gong F; Chen X
Iran J Basic Med Sci; 2015 Jun; 18(6):610-5. PubMed ID: 26221486
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase.
Xu JW; Morita I; Ikeda K; Miki T; Yamori Y
Mol Endocrinol; 2007 Feb; 21(2):564-73. PubMed ID: 17095576
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction.
Devaraj S; Yun JM; Adamson G; Galvez J; Jialal I
Cardiovasc Res; 2009 Dec; 84(3):479-84. PubMed ID: 19620133
[TBL] [Abstract][Full Text] [Related]
27. Palmitate induces C-reactive protein expression in human aortic endothelial cells. Relevance to fatty acid-induced endothelial dysfunction.
Mugabo Y; Mukaneza Y; Renier G
Metabolism; 2011 May; 60(5):640-8. PubMed ID: 20727556
[TBL] [Abstract][Full Text] [Related]
28. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells.
Venugopal SK; Devaraj S; Yuhanna I; Shaul P; Jialal I
Circulation; 2002 Sep; 106(12):1439-41. PubMed ID: 12234944
[TBL] [Abstract][Full Text] [Related]
29. Bubble-Induced Endothelial Microparticles Promote Endothelial Dysfunction.
Yu X; Xu J; Huang G; Zhang K; Qing L; Liu W; Xu W
PLoS One; 2017; 12(1):e0168881. PubMed ID: 28114372
[TBL] [Abstract][Full Text] [Related]
30. Endothelial injury and repair in systemic vasculitis of the young.
Clarke LA; Hong Y; Eleftheriou D; Shah V; Arrigoni F; Klein NJ; Brogan PA
Arthritis Rheum; 2010 Jun; 62(6):1770-80. PubMed ID: 20178138
[TBL] [Abstract][Full Text] [Related]
31. Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans.
Cheng F; Wang Y; Li J; Su C; Wu F; Xia WH; Yang Z; Yu BB; Qiu YX; Tao J
Int J Cardiol; 2013 Aug; 167(3):936-42. PubMed ID: 22465347
[TBL] [Abstract][Full Text] [Related]
32. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
[TBL] [Abstract][Full Text] [Related]
33. Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells.
Woollard KJ; Phillips DC; Griffiths HR
Clin Exp Immunol; 2002 Nov; 130(2):256-62. PubMed ID: 12390313
[TBL] [Abstract][Full Text] [Related]
34. Endothelial microparticles are increased in congenital heart diseases and contribute to endothelial dysfunction.
Lin ZB; Ci HB; Li Y; Cheng TP; Liu DH; Wang YS; Xu J; Yuan HX; Li HM; Chen J; Zhou L; Wang ZP; Zhang X; Ou ZJ; Ou JS
J Transl Med; 2017 Jan; 15(1):4. PubMed ID: 28049487
[TBL] [Abstract][Full Text] [Related]
35. Endothelium-derived microparticles impair endothelial function in vitro.
Brodsky SV; Zhang F; Nasjletti A; Goligorsky MS
Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1910-5. PubMed ID: 15072974
[TBL] [Abstract][Full Text] [Related]
36. [Role of NADPH oxidase in endothelial cell dysfunction induced by endothelial microparticles].
Cheng F; Tao J; Feng JQ; Yang CT; Wang Y; Zhang YY; Zhang XL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1103-6. PubMed ID: 20501406
[TBL] [Abstract][Full Text] [Related]
37. C-reactive protein decreases prostacyclin release from human aortic endothelial cells.
Venugopal SK; Devaraj S; Jialal I
Circulation; 2003 Oct; 108(14):1676-8. PubMed ID: 14504187
[TBL] [Abstract][Full Text] [Related]
38. Increased circulating endothelial microparticles in children with FMF.
Yel S; Dursun İ; Çetin F; Baştuğ F; Tülpar S; Düşünsel R; Gündüz Z; Poyrazoğlu H; Yılmaz K
Biomarkers; 2018 Sep; 23(6):558-562. PubMed ID: 29611726
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II receptor type 1 autoantibodies promote endothelial microparticles formation through activating p38 MAPK pathway.
Yang S; Zhong Q; Qiu Z; Chen X; Chen F; Mustafa K; Ding D; Zhou Y; Lin J; Yan S; Deng Y; Wang M; Zhou Y; Liao Y; Zhou Z
J Hypertens; 2014 Apr; 32(4):762-70. PubMed ID: 24609215
[TBL] [Abstract][Full Text] [Related]
40. New immunophenotype of circulating endothelial progenitor cells and endothelial microparticles in patients with erectile dysfunction and metabolic syndrome: effects of tadalafil administration.
La Vignera S
Int Angiol; 2011 Oct; 30(5):415-23. PubMed ID: 21804479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
